111.94

0.01% -0.01

Novo Nordisk Adr (NVO)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt NVO? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$111.95

Offen:

$112.88

24-Stunden-Volumen:

4.43M

Relative Volume:

1.06

Marktkapitalisierung:

$498.76B

Einnahmen:

$37.42B

Nettoeinkommen (Verlust:

$13.05B

KGV:

46.49

EPS:

2.4077

Netto-Cashflow:

$9.51B

1W Leistung:

-1.27%

1M Leistung:

-5.14%

6M Leistung:

-13.37%

1J Leistung:

+14.60%

1-Tages-Spanne:

$111.79

$113.02

1-Wochen-Bereich:

$107.24

$113.76

52-Wochen-Spanne:

$94.73

$148.15

Novo Nordisk Adr Stock (NVO) Company Profile

Firmenname

Novo Nordisk Adr

Sektor

Healthcare (1179)

Branche

Drug Manufacturers - General (18)

Telefon

Adresse

Mitarbeiter

69,260

Twitter

@novonordisk

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

NVO's Discussions on Twitter

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-05-30	Eingeleitet	Goldman	Buy
2024-04-12	Eingeleitet	BMO Capital Markets	Outperform
2024-01-23	Eingeleitet	Morgan Stanley	Overweight
2024-01-16	Fortgesetzt	UBS	Neutral
2023-12-01	Eingeleitet	Cantor Fitzgerald	Overweight
2023-10-02	Eingeleitet	Argus	Buy
2023-07-14	Eingeleitet	HSBC Securities	Buy
2022-07-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-06-28	Herabstufung	UBS	Neutral → Sell
2022-06-27	Hochstufung	Exane BNP Paribas	Underperform → Neutral
2022-06-07	Hochstufung	JP Morgan	Neutral → Overweight
2022-05-31	Hochstufung	Guggenheim	Neutral → Buy
2022-04-25	Hochstufung	Cowen	Market Perform → Outperform
2022-04-12	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2022-03-16	Hochstufung	Deutsche Bank	Hold → Buy
2022-01-25	Herabstufung	Liberum	Hold → Sell
2021-12-20	Herabstufung	JP Morgan	Overweight → Neutral
2021-12-17	Herabstufung	Deutsche Bank	Buy → Hold
2021-01-20	Herabstufung	Credit Suisse	Outperform → Neutral
2021-01-15	Eingeleitet	Deutsche Bank	Buy
2020-09-29	Eingeleitet	Berenberg	Hold
2020-07-06	Herabstufung	BofA Securities	Buy → Neutral
2020-05-11	Herabstufung	UBS	Buy → Neutral
2020-05-04	Eingeleitet	Cowen	Market Perform
2020-03-16	Hochstufung	BofA/Merrill	Neutral → Buy
2020-01-03	Herabstufung	Guggenheim	Buy → Neutral
2019-11-18	Hochstufung	Barclays	Equal Weight → Overweight
2019-09-17	Hochstufung	Citigroup	Neutral → Buy
2019-08-30	Herabstufung	Jefferies	Hold → Underperform
2019-06-20	Herabstufung	Deutsche Bank	Buy → Hold
2019-06-11	Hochstufung	Barclays	Underweight → Equal Weight
2019-04-29	Hochstufung	Credit Suisse	Neutral → Outperform
2019-01-29	Eingeleitet	Exane BNP Paribas	Outperform
2018-12-11	Fortgesetzt	Jefferies	Hold
2018-10-09	Eingeleitet	Guggenheim	Buy
2017-12-29	Hochstufung	JP Morgan	Underweight → Neutral
2017-12-06	Hochstufung	BofA/Merrill	Neutral → Buy
2017-12-01	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2017-09-25	Herabstufung	Exane BNP Paribas	Outperform → Neutral
2017-09-06	Hochstufung	BofA/Merrill	Underperform → Neutral

Alle ansehen

Novo Nordisk Adr Aktie (NVO) Neueste Nachrichten

Oct 31, 2024

Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - Benzinga

Oct 31, 2024

Oct 23, 2024

Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo Finance

Oct 23, 2024

Oct 21, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 21, 2024

Oct 18, 2024

Why this money manager sees FirstService, Novo Nordisk and Microsoft as good long-term holdings - The Globe and Mail

Oct 18, 2024

Oct 16, 2024

Monitoring Melco Resorts & Entertainment Ltd ADR (MLCO) after recent insider movements - Knox Daily

Oct 09, 2024

Oct 07, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024

Oct 03, 2024

Novo Nordisk Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since September 2022 — Data Talk - Morningstar

Oct 03, 2024

Oct 02, 2024